Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT07263932
Eligibility Criteria:
Inclusion Criteria:
* Patients scheduled for elective total hip arthroplasty (THA) under spinal anesthesia
* ASA physical status I-II
* Age ≥18 years
* Body Mass Index (BMI) between 18-35 kg/m²
* Patients who provide written informed consent
Exclusion Criteria:
* Age \<18 years
* ASA physical status ≥III
* Known allergy or contraindication to study medications (local anesthetics, opioids, etc.)
* Severe cardiac, renal, hepatic, or pulmonary failure
* Revision total hip arthroplasty
* Coagulopathy or anticoagulant use
* Local infection or neuropathic findings at the injection site
* Chronic inflammatory diseases or chronic corticosteroid use
* Diagnosed neuropsychiatric disorders
* Pregnancy or lactation
* Inability or unwillingness to read, understand, or sign the informed consent form
* Obesity (BMI \>35 kg/m²)
* Failed spinal anesthesia or conversion to general anesthesia
* Active malignancy or patients receiving radiotherapy/chemotherapy
* Active systemic infection or ongoing antibiotic therapy (except prophylaxis)
* Contraindication to regional anesthesia techniques
* Chronic opioid or analgesic use for pain disorders
* History of intracranial mass, increased intracranial pressure, epilepsy, cerebrovascular accident, neuromuscular disease, or motor/sensory deficits
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07263932
Study Brief:
Protocol Section:
NCT07263932